Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Nicholls SJ"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 48
Tytuł:
Serial changes in vessel walls of renal arteries after catheter-based renal artery denervation: insights from volumetric computed tomography analysis
Autorzy:
Kataoka Y
Delacroix S
Sidharta S
Andrews J
Nicholls SJ
Tsioufis CP
Papademetriou V
Worthley SG
Pokaż więcej
Temat:
renal artery
blood pressure
resistant hypertension
renal denervation
computed tomography
Diseases of the genitourinary system. Urology
RC870-923
Źródło:
International Journal of Nephrology and Renovascular Disease, Vol Volume 11, Pp 259-266 (2018)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/serial-changes-in-vessel-walls-of-renal-arteries-after-catheter-based--peer-reviewed-article-IJNRD; https://doaj.org/toc/1178-7058
Dostęp URL:
https://doaj.org/article/be7b9928453345cd94258bae62847555  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Anacetrapib as a potential cardioprotective strategy
Autorzy:
Di Bartolo BA
Nicholls SJ
Pokaż więcej
Temat:
Anacetrapib
CETP
lipids
atherosclerosis
cardiovascular disease
Therapeutics. Pharmacology
RM1-950
Źródło:
Drug Design, Development and Therapy, Vol Volume 11, Pp 3497-3502 (2017)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/anacetrapib-as-a-potential-cardioprotective-strategy-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:
https://doaj.org/article/e5e2985e34a24c63b8046b244336bf46  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?
Autorzy:
Scherer DJ
Nicholls SJ
Pokaż więcej
Temat:
Diseases of the circulatory (Cardiovascular) system
RC666-701
Źródło:
Vascular Health and Risk Management, Vol 2015, Iss default, Pp 203-209 (2015)
Opis pliku:
electronic resource
Relacje:
http://www.dovepress.com/lowering-triglycerides-to-modify-cardiovascular-risk-will-icosapent-de-peer-reviewed-article-VHRM; https://doaj.org/toc/1178-2048
Dostęp URL:
https://doaj.org/article/6455fd0fedf94d0ba99bafca8412772d  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis.
Autorzy:
Wong NKP; Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.; Department of Cardiology, St. Vincent's Hospital, Darlinghurst, NSW 2010, Australia.
Solly EL; Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.; Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
Le R; Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.; College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia.
Nankivell VA; Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.; Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
Mulangala J; Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.; Heart Foundation, Brisbane, QLD 4000, Australia.
Psaltis PJ; Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.; Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
Nicholls SJ; Victorian Heart Institute, Monash University, Clayton, VIC 3800, Australia.
Ng MKC; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.; Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.
Bursill CA; Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.; Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
Tan JTM; Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.; Faculty of Medicine and Health, The University of Sydney School of Medicine, Camperdown, NSW 2050, Australia.; Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA 5005, Australia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 15; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:
Journal Article
MeSH Terms:
Angiogenesis*
Endothelial Cells*/metabolism
Animals ; Mice ; Hindlimb/blood supply ; Hypoxia/metabolism ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Inflammation/metabolism ; Ischemia/metabolism ; Neovascularization, Pathologic/metabolism ; Neovascularization, Physiologic/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program.
Autorzy:
Nicholls SJ; Victorian Heart Institute, Monash University, Clayton, VIC, Australia.
Tofé S; Department of Endocrinology and Nutrition, University Hospital Son Espases, Palma, Spain.
le Roux CW; Diabetes Complications Research Centre, Conway Institute, School of Medicine, University College Dublin, Dublin, Ireland.; Diabetes Research Centre, Ulster University, Coleraine, UK.
D'Alessio DA; Division of Endocrinology, Department of Medicine, Duke Molecular Physiology Institute, Duke University, Durham, NC, USA.
Wiese RJ; Eli Lilly and Company, Indianapolis, IN, USA.
Pavo I; Eli Lilly Regional Operations GmbH, Vienna, Austria.
Brown K; Eli Lilly and Company, Indianapolis, IN, USA.
Weerakkody GJ; Eli Lilly and Company, Indianapolis, IN, USA.
Zeytinoglu M; Eli Lilly and Company, Indianapolis, IN, USA.
Romera IC; Eli Lilly and Company, Avda. de La Industria 30, 28108, Alcobendas, Madrid, Spain. romera_.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Feb 10; Vol. 23 (1), pp. 63. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Metabolic Syndrome*/diagnosis
Metabolic Syndrome*/drug therapy
Metabolic Syndrome*/epidemiology
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Glucagon-Like Peptide-2 Receptor*
Adult ; Humans ; Prevalence ; Insulin Glargine ; Gastric Inhibitory Polypeptide ; Obesity ; Body Weight ; Hypoglycemic Agents/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Managing hypercholesterolaemia.
Autorzy:
Nelson AJ; Royal Adelaide Hospital.; Victorian Heart Institute, Monash University, Melbourne.; Victorian Heart Hospital, MonashHeart and Intensive Care, Monash Health, Melbourne.
Nicholls SJ; Royal Adelaide Hospital.; Victorian Heart Institute, Monash University, Melbourne.; Victorian Heart Hospital, MonashHeart and Intensive Care, Monash Health, Melbourne.
Pokaż więcej
Źródło:
Australian prescriber [Aust Prescr] 2024 Feb; Vol. 47 (1), pp. 7-14.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Pericoronary adipose tissue attenuation on coronary computed tomography angiography associates with male sex and Indigenous Australian status.
Autorzy:
Yuvaraj J; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.; School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
Lim E; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.
Vo T; Division of Medicine, Royal Darwin Hospital, Tiwi, NT, Australia.; Department of Cardiology, Gold Coast University Hospital, Southport, QLD, Australia.
Huynh D; Division of Medicine, Royal Darwin Hospital, Tiwi, NT, Australia.
Rocco C; Division of Medicine, Royal Darwin Hospital, Tiwi, NT, Australia.
Nerlekar N; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.; School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
Cheng K; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.; School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
Lin A; Cedars-Sinai Medical Center, Biomedical Imaging Research Institute, Los Angeles, CA, USA.
Dey D; Cedars-Sinai Medical Center, Biomedical Imaging Research Institute, Los Angeles, CA, USA.
Nicholls SJ; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.; School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
Kangaharan N; Division of Medicine, Royal Darwin Hospital, Tiwi, NT, Australia.
Wong DTL; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia. .; School of Clinical Sciences, Monash University, Clayton, VIC, Australia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 19; Vol. 13 (1), pp. 15509. Date of Electronic Publication: 2023 Sep 19.
Typ publikacji:
Journal Article
MeSH Terms:
Computed Tomography Angiography*
RNA, Long Noncoding*
Humans ; Female ; Male ; Adult ; Middle Aged ; Australian Aboriginal and Torres Strait Islander Peoples ; Retrospective Studies ; Australia ; Adipose Tissue/diagnostic imaging ; Inflammation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Providing guideline-recommended preventive cardiovascular care to Aboriginal and Torres Strait Islander women: exploring gender differences with a medical record review in primary health care.
Autorzy:
McBride K; Allied Health and Human Performance, University of South Australia, Adelaide, SA 5000, Australia; and Wardliparingga Aboriginal Health Equity Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia.
Howard NJ; Wardliparingga Aboriginal Health Equity Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia; and Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA 5000, Australia.
Franks C; Wardliparingga Aboriginal Health Equity Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia; and Aboriginal Women's Advisory Group, Adelaide, SA, Australia.
King V; Aboriginal Women's Advisory Group, Adelaide, SA, Australia; and Central Australian Aboriginal Congress, Alice Springs, NT 0870, Australia.
Wade V; Aboriginal Women's Advisory Group, Adelaide, SA, Australia; and Menzies School of Health Research, Casuarina, NT 0811, Australia.
Dowling A; Aboriginal Women's Advisory Group, Adelaide, SA, Australia; and College of Medicine and Public Health, Flinders University, Bedford Park, SA 5042, Australia.
Rigney J; Aboriginal Women's Advisory Group, Adelaide, SA, Australia.
Burton N; Aboriginal Women's Advisory Group, Adelaide, SA, Australia; and Ngaanyatjarra, Pitjantjatjara, Yankunytjatjara Women's Council, Alice Springs, NT 0870, Australia.
Mitchell JA; Aboriginal Women's Advisory Group, Adelaide, SA, Australia; and The Heart Foundation of Australia, Woolloomooloo, NSW 2011, Australia.
Hillier S; Allied Health and Human Performance, University of South Australia, Adelaide, SA 5000, Australia.
Nicholls SJ; Victorian Heart Institute, Monash University, Clayton, Vic. 3168, Australia.
Paquet C; Allied Health and Human Performance, University of South Australia, Adelaide, SA 5000, Australia; and Faculté des Sciences de l'Administration, Université Laval, Québec, QC G1V 0A6, Canada.
Brown A; Wardliparingga Aboriginal Health Equity Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia; and Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA 5000, Australia.
Pokaż więcej
Źródło:
Australian journal of primary health [Aust J Prim Health] 2022 Dec; Vol. 28 (6), pp. 498-507.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiovascular Diseases*/prevention & control
Health Services, Indigenous*
Primary Health Care*
Female ; Humans ; Male ; Medical Records ; Australian Aboriginal and Torres Strait Islander Peoples ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transitioning to active-controlled trials to evaluate cardiovascular safety and efficacy of medications for type 2 diabetes.
Autorzy:
McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center and Parkland Health and Hospital System, 5323 Harry Hines Blvd, Dallas, TX, 75235-8830, USA. .
D'Alessio D; Division of Endocrinology, Duke University Medical Center, Durham, NC, USA.
Nicholls SJ; Monash Cardiovascular Research Centre, Victorian Heart Institute, Monash University, Melbourne, Australia.
Nissen SE; Cleveland Clinic Coordinating Center for Clinical Research, Cleveland Clinic, Cleveland, OH, USA.
Riesmeyer JS; Eli Lilly and Company, Indianapolis, IN, USA.
Pavo I; Eli Lilly Regional Operations GmbH, Vienna, Austria.
Sethuraman S; Eli Lilly and Company, Indianapolis, IN, USA.
Heilmann CR; Eli Lilly and Company, Indianapolis, IN, USA.
Kaiser JJ; Eli Lilly and Company, Indianapolis, IN, USA.
Weerakkody GJ; Eli Lilly and Company, Indianapolis, IN, USA.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2022 Aug 24; Vol. 21 (1), pp. 163. Date of Electronic Publication: 2022 Aug 24.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cardiovascular Diseases*/epidemiology
Diabetes Mellitus, Type 2*/drug therapy
Hypoglycemic Agents*/adverse effects
Bayes Theorem ; Drugs, Investigational/therapeutic use ; Glucagon-Like Peptide 1/adverse effects ; Glucagon-Like Peptide-1 Receptor/agonists ; Humans ; Randomized Controlled Trials as Topic ; Sodium-Glucose Transporter 2 Inhibitors/adverse effects ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels.
Autorzy:
Nelson AJ; Victorian Heart Institute, Monash University, Clayton, VIC 3800, Australia.
Sniderman AD; Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.
Ditmarsch M; NewAmsterdam Pharma, 1411 DC Naarden, The Netherlands.
Dicklin MR; Midwest Biomedical Research, Addison, IL 60101, USA.
Nicholls SJ; Victorian Heart Institute, Monash University, Clayton, VIC 3800, Australia.
Davidson MH; NewAmsterdam Pharma, 1411 DC Naarden, The Netherlands.
Kastelein JJP; Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Aug 20; Vol. 23 (16). Date of Electronic Publication: 2022 Aug 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Atherosclerosis*
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Animals ; Apolipoproteins B/metabolism ; Cholesterol Ester Transfer Proteins/metabolism ; Cholesterol, HDL/metabolism ; Cholesterol, LDL ; Triglycerides
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Atherogenic index of plasma is associated with epicardial adipose tissue volume assessed on coronary computed tomography angiography.
Autorzy:
Yuvaraj J; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.; School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
Isa M; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.
Che ZC; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.
Lim E; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.
Nerlekar N; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.
Nicholls SJ; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.; School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
Seneviratne S; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.; School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
Lin A; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia.; School of Clinical Sciences, Monash University, Clayton, VIC, Australia.; Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Dey D; Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Wong DTL; Monash Cardiovascular Research Centre, Victorian Heart Institute, MonashHeart and Monash University, Monash Health, 246 Clayton Road, Clayton, VIC, 3168, Australia. .; School of Clinical Sciences, Monash University, Clayton, VIC, Australia. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jun 10; Vol. 12 (1), pp. 9626. Date of Electronic Publication: 2022 Jun 10.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Coronary Artery Disease*/diagnostic imaging
Diabetes Mellitus, Type 2*
Plaque, Atherosclerotic*
Adipose Tissue/diagnostic imaging ; Aged ; Computed Tomography Angiography/methods ; Coronary Angiography/methods ; Humans ; Male ; Middle Aged ; Pericardium/diagnostic imaging ; Tomography, X-Ray Computed
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 48

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies